How many employees does hVIVO have this year?
hVIVO has 132 undefined employees this year.
hVIVO Employees 2025
hVIVO Employees
132
Ticker
HVO.L
ISIN
GB00B9275X97
WKN
A1KAME
In 2025, hVIVO employed 132 people, a 0% change from the 132 number of employees in the previous year.
hVIVO Aktienanalyse
What does hVIVO do?
Open Orphan PLC is a global company specializing in the development and marketing of therapeutics and vaccines. The company was formed in 2017 through the merger of Venn Life Sciences and Open Orphan Ltd. It was successfully listed on the London Stock Exchange in 2019 and has since expanded and established itself as a major player in the biotechnology industry. Open Orphan's business model is based on collaboration with pharmaceutical and biotech companies to conduct clinical trials and advance the development of therapeutics and vaccines. The company offers innovative and customized solutions tailored to the needs of its clients. Open Orphan operates various divisions, including "Venn Life Sciences," "Clinical Research Services," and "Drug Development Services." These divisions work closely together to conduct a wide range of clinical trials, from Phase I to Phase IV studies. The company specializes in conducting clinical trials for rare diseases such as congenital heart failure or rare neurological disorders. It also conducts studies in the field of infectious diseases, such as COVID-19. In addition to its role as a Contract Research Organization (CRO), Open Orphan also offers its own products. This includes the "COVID-19 Human Challenge Trial" program, which involves intentionally infecting volunteers with the coronavirus to test the efficacy of vaccines and therapeutics. Another product offered by Open Orphan is the "Venus Flu Study," a clinical trial for a novel flu vaccine. Open Orphan also operates its own platform called the "Orphan Drug Accelerator," an online marketplace specializing in accelerating the market launch of orphan drugs. Biotech companies, investors, and regulatory authorities can connect and collaborate on this platform to expedite the development and marketing of orphan drugs. Overall, Open Orphan is an emerging company in the biotechnology industry, specializing in conducting clinical trials and developing and marketing therapeutics and vaccines. With its innovative and tailored solutions, as well as its own products, the company has already attracted a variety of customers and investors. hVIVO ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining hVIVO's Employee Base
hVIVO's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding hVIVO's operational capacity and future potential.
Year-to-Year Comparison
Assessing hVIVO's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
hVIVO's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in hVIVO’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about hVIVO stock
How many employees did hVIVO have compared to the previous year?
Compared to the previous year, hVIVO had 0% more employees.
What impact did the number of employees have on the company hVIVO?
The number of employees has a direct impact on the efficiency and productivity of hVIVO. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of hVIVO?
The number of employees can also have an impact on investors of hVIVO, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of hVIVO affect the company?
An increase in equity of hVIVO can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in hVIVO's equity affect the company?
A reduction in equity of hVIVO can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of hVIVO?
Some factors that can influence the equity of hVIVO include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of hVIVO so important for investors?
The equity of hVIVO is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at hVIVO influence the company?
The number of employees at hVIVO can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at hVIVO evolved in recent years?
In recent years, the number of employees at hVIVO has changed by 0.
How many employees does hVIVO currently have?
hVIVO currently has 132 undefined employees.
Why is the number of employees important for investors of hVIVO?
The number of employees is important for investors of hVIVO as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can hVIVO take to change the number of employees?
To change the number of employees, hVIVO can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does hVIVO pay?
Over the past 12 months, hVIVO paid a dividend of 0 GBP . This corresponds to a dividend yield of about 2.34 %. For the coming 12 months, hVIVO is expected to pay a dividend of 0 GBP.
What is the dividend yield of hVIVO?
The current dividend yield of hVIVO is 2.34 %.
When does hVIVO pay dividends?
hVIVO pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of hVIVO?
hVIVO paid dividends every year for the past 0 years.
What is the dividend of hVIVO?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 1.04 %.
In which sector is hVIVO located?
hVIVO is assigned to the 'Health' sector.
Wann musste ich die Aktien von hVIVO kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of hVIVO from 5/20/2024 amounting to 0.002 GBP, you needed to have the stock in your portfolio before the ex-date on 4/18/2024.
When did hVIVO pay the last dividend?
The last dividend was paid out on 5/20/2024.
What was the dividend of hVIVO in the year 2024?
In the year 2024, hVIVO distributed 0.005 GBP as dividends.
In which currency does hVIVO pay out the dividend?
The dividends of hVIVO are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von hVIVO
Our stock analysis for hVIVO Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of hVIVO Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.